Cargando…
Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector Nucleases
Chronic hepatitis B virus (HBV) infection remains an important global health problem. Stability of the episomal covalently closed circular HBV DNA (cccDNA) is largely responsible for the modest curative efficacy of available therapy. Since licensed anti-HBV drugs have a post-transcriptional mechanis...
Autores principales: | Bloom, Kristie, Ely, Abdullah, Mussolino, Claudio, Cathomen, Toni, Arbuthnot, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808145/ https://www.ncbi.nlm.nih.gov/pubmed/23883864 http://dx.doi.org/10.1038/mt.2013.170 |
Ejemplares similares
-
Inhibition of replication of hepatitis B virus using transcriptional repressors that target the viral DNA
por: Bloom, Kristie, et al.
Publicado: (2019) -
Improved Specificity and Safety of Anti-Hepatitis B Virus TALENs Using Obligate Heterodimeric FokI Nuclease Domains
por: Smith, Tiffany, et al.
Publicado: (2021) -
Chimerization Enables Gene Synthesis and Lentiviral Delivery of Customizable TALE-Based Effectors
por: Fang, Yongxing, et al.
Publicado: (2020) -
A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity
por: Mussolino, Claudio, et al.
Publicado: (2011) -
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells
por: Holkers, Maarten, et al.
Publicado: (2013)